Axol Bioscience
Sells live human cell cultures and provides services such as genome editing to researchers.
Launch date
Employees
Market cap
-
Enterprise valuation
$13—20m (Dealroom.co estimates Aug 2017.)
Company register number 08340031
Cambridge England (HQ)
Financials
Estimates*
| GBP | 2015 | 2016 |
|---|---|---|
| Revenues | <1m | <1m |
| % growth | - | 98 % |
| EBITDA | (<1m) | (<1m) |
| % EBITDA margin | (214 %) | (95 %) |
| Profit | (<1m) | (<1m) |
| % profit margin | (266 %) | (128 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $1.4m | Seed | |
£970k | Early VC | ||
£2.5m | Seed | ||
N/A | Merger | ||
* | £3.2m | - | |
| Total Funding | $10.2m | ||
Related Content
Recent News about Axol Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
